These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 19681115)

  • 1. Ten years after: "I'd love to change the world".
    Tommaso CL
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):427. PubMed ID: 19681115
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors affecting post minimally invasive direct coronary artery bypass grafting incidence of myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting and mortality of cardiac origin.
    Kofidis T; Gerd Paeschke H; Lichtenberg A; Emmert M; Woitek F; Didilis V; Haverich A; Klima U
    Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):49-53. PubMed ID: 18786942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time for left main stenting in patients with LV dysfunction? Proceed with caution!
    Uretsky BF
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):594-5. PubMed ID: 20333658
    [No Abstract]   [Full Text] [Related]  

  • 4. To excel or to confirm? That is the question.
    Dangas G
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):944. PubMed ID: 21598346
    [No Abstract]   [Full Text] [Related]  

  • 5. Percutaneous revascularization of the "unprotected" left main during acute myocardial infarction: "Dare to struggle! Dare to win!".
    Morrison DA
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):22-4. PubMed ID: 19089931
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: One year perspective on COURAGE.
    Sedlis SP; Boden WE; Weintraub WS; Maron DS; O'Rourke RA; Berman DS; Mancini GB;
    Catheter Cardiovasc Interv; 2009 Feb; 73(3):428. PubMed ID: 19133682
    [No Abstract]   [Full Text] [Related]  

  • 7. Stenting unprotected left main: the outcome is not always favorable.
    Colombo A
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):539-40. PubMed ID: 18307235
    [No Abstract]   [Full Text] [Related]  

  • 8. The value of clinical wisdom in randomised studies, real-world registries and new hypotheses.
    Bernardi G; Morocutti G; Spedicato L; Zanuttini D
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):313-7. PubMed ID: 17443094
    [No Abstract]   [Full Text] [Related]  

  • 9. Stenting the coronaries and bypassing the evidence in patients with multivessel coronary artery disease: time to set the record straight.
    Zingone B
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):362-70. PubMed ID: 17443104
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of three-year outcomes after coronary stenting versus coronary artery bypass grafting in patients with multivessel coronary disease, including involvement of the left anterior descending coronary artery proximally (a subanalysis of the arterial revascularization therapies study trial).
    Aoki J; Ong AT; Arampatzis CA; Vijaykumar M; Rodriguez Granillo GA; Disco CM; Serruys PW
    Am J Cardiol; 2004 Sep; 94(5):627-31. PubMed ID: 15342295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SYNTAX score in practice: an aid for patient selection for complex PCI.
    Feldman T
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):618-9. PubMed ID: 19309708
    [No Abstract]   [Full Text] [Related]  

  • 12. CABG versus DES PCI in diabetics with multivessel disease: back to the BARI registry.
    Hillegass W
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):59-60. PubMed ID: 19089939
    [No Abstract]   [Full Text] [Related]  

  • 13. Validating the EXCEL hypothesis: a propensity score matched 3-year comparison of percutaneous coronary intervention versus coronary artery bypass graft in left main patients with SYNTAX score ≤32.
    Capodanno D; Caggegi A; Capranzano P; Cincotta G; Miano M; Barrano G; Monaco S; Calvo F; Tamburino C
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):936-43. PubMed ID: 21547994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left anterior descending coronary artery revascularization patient-tailored therapy?
    Abbate A; Vetrovec GW
    JACC Cardiovasc Interv; 2008 Oct; 1(5):492-3. PubMed ID: 19463350
    [No Abstract]   [Full Text] [Related]  

  • 15. CABG or PCI: which is better? Bypass or angioplasty with stent? For multivessel disease, some say surgery is the superior treatment.
    Health News; 2006 May; 12(5):8-10. PubMed ID: 16685751
    [No Abstract]   [Full Text] [Related]  

  • 16. PRO: Preoperative coronary revascularization in high-risk patients undergoing vascular surgery.
    Landesberg G; Mosseri M
    Anesth Analg; 2008 Mar; 106(3):759-63. PubMed ID: 18292414
    [No Abstract]   [Full Text] [Related]  

  • 17. The evolution of repeat coronary artery surgery.
    Noyez L
    EuroIntervention; 2009 May; 5 Suppl D():D30-3. PubMed ID: 19736067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-stent technique: a dead duck or alive and kicking?
    Belardi JA
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):321-2. PubMed ID: 19642180
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug-eluting stents or drug-eluting conduits for multivessel disease?
    Alfieri O; Maisano F; Benussi S; Toracca L; Castiglioni A
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):359-61. PubMed ID: 17443103
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimizing outcomes for patients with severe carotid and coronary disease.
    Casserly IP
    Catheter Cardiovasc Interv; 2009 Feb; 73(2):143-4. PubMed ID: 19156876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.